Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New additions to Medtronic's product range

This article was originally published in Clinica

Executive Summary

Medtronic has received US FDA clearance to market its Sprint 6932 ICD leads and has launched a cerebral catheter. Introduced in Europe in May, the 6932 is the first of a new family of defibrillator leads for active-can devices that feature multiple lumens and narrower conductors. The 7.8F lead uses Medtronic's tined, steroid-eluting electrode. Clinical trials of the 6942, a triple-lumen lead for defibrillating both the right ventricle and the superior vena cava, began in Europe in July. An active fixation version (6943) is expected to enter trials in the near future.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT088790

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel